Search filters

List of works by Steven R Alberts

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

scientific article

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

scientific article

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

scientific article published on 19 November 2005

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

scientific article

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

scientific article published in August 2002

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies

scientific article

A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer

scientific article

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

scientific article published in October 2002

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

scientific article

A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu

scientific article

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

scientific article

A phase II study of topical ceramides for cutaneous breast cancer

scientific article published on 01 July 2003

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

scientific article

A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults

scientific article

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

scientific article

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer

scientific article

Accomplishments in 2007 in the management of curable metastatic colorectal cancer

scientific article published on May 2008

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

scientific article published on 4 October 2017

Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators

scientific article

Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147.

scientific article published on 8 April 2016

Alternate dosing of cetuximab for patients with metastatic colorectal cancer ⬇️

scientific article published on March 1, 2013

Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N99

scientific article

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

scientific article

Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)

scientific article published on 25 January 2020

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.

scientific article published on 20 May 2016

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

scientific article published on 11 December 2015

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set

scientific article

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

scientific article published on 25 September 2018

Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials

scientific article published on 22 December 2016

Association of immune markers and Immunoscore with survival of stage III colon carcinoma (CC) patients (pts) treated with adjuvant FOLFOX: NCCTG N0147 (Alliance)

Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).

scientific article

Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147

scientific article published on April 2013

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

article by Bruce J. Giantonio et al published 20 April 2007 in Journal of Clinical Oncology

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design ⬇️

scientific article published on February 23, 2013

Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).

scientific article published on May 2008

Building a protocol expressway: the case of Mayo Clinic Cancer Center

scientific article published on 29 June 2009

CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study

scientific article

Chemotherapy for colorectal cancer liver metastases

scientific article published on 06 October 2008

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.

scientific article

Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials

scientific article published on 26 February 2020

Clinical impact of celiac ganglia metastasis upon pancreatic ductal adenocarcinoma

scientific article published on 14 November 2019

Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.

scientific article

Colorectal cancer in alaska native people, 2005-2009 ⬇️

scientific article published on September 1, 2012

Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone

scientific article published on 12 September 2018

Combined Modality Therapy Including Intraoperative Electron Irradiation for Locally Recurrent Colorectal Cancer

article

Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer

scientific article

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

scientific article published in March 2002

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.

scientific article

Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

scientific article

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

scientific article published on 05 April 2020

Current Use and Surgical Efficacy of Laparoscopic Colectomy in Colon Cancer ⬇️

scientific article published on April 24, 2013

DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147).

scientific article

Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database

scientific article published on 8 February 2016

Differences in cancer incidence among Indians in Alaska and New Mexico and U.S. Whites, 1993-2002

scientific article published on 01 August 2006

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis

scientific article

Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group

scientific article published on 23 February 2006

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581

scientific article

Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)

scientific article published on 06 March 2020

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer.

scientific article published on 23 November 2016

Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer ⬇️

scientific article published on April 4, 2012

Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.

scientific article published on 24 October 2012

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

scientific article published on 16 January 2020

Evolving role of chemotherapy in resected liver metastases

scientific article published on 01 November 2006

Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance).

scientific article published on February 2017

Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial

scientific article published in July 2006

Functional and clinical significance of variants localized to 8q24 in colon cancer

scientific article

Gastric cancer in Alaska Native people: A cancer health disparity.

scientific article published on 7 July 2018

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial

scientific article

Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial

scientific article published in December 2004

Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial

scientific article

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

scientific article

Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study

scientific article

Gemcitabine plus cisplatin in advanced pancreatic cancer

scientific article published on 01 March 2007

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial

scientific article

Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.

scientific article published in June 2007

Genetic Variant Associated with Survival of Patients with Stage II-III Colon Cancer

scientific article published on 04 December 2019

Genetic predictors of severe skin toxicity in stage III colon cancer patients treated with cetuximab: NCCTG N0147 (Alliance)

scientific article published on 17 November 2020

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019

scientific article published on 01 April 2019

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative

scientific article published on 12 March 2020

Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Group (NCCTG) Phase II Study, 92-46-52 ⬇️

scientific article published on May 13, 2011

High-folate diets and breast cancer survival in a prospective cohort study

scientific article published in January 2002

Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trials

scientific article

History of the development of antiemetic guidelines at Mayo Clinic Rochester

scientific article

Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.

scientific article

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.

scientific article

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.

scientific article

Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer.

scientific article published on January 2008

Impact of prognostic factors on clinical outcome after resection of colorectal pulmonary metastases

scientific article published on May 2006

Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT.

scientific article

Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers

scientific article published on 11 May 2015

Incremental costs of enrolling cancer patients in clinical trials: a population-based study

scientific article

Inter-tumoral heterogeneity of CD3 and CD8 T-cell densities in the microenvironment of DNA mismatch repair-deficient colon cancers: implications for prognosis

scientific article published on 09 October 2018

Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas

scientific article published on 01 January 2006

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7 ⬇️

scientific article published on December 28, 2010

Is There a Role for Liver Transplantation in the Treatment of Patients With Metastatic Colorectal Cancer?

scientific article published on 01 February 2020

Is a solitary inguinal lymph node metastasis from adenocarcinoma of the rectum really a metastasis?

scientific article published on 25 February 2009

Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group

scientific article

KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).

scientific article

Liver transplantation for unresectable perihilar cholangiocarcinoma

scientific article

Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma

scientific article published on 01 September 2005

Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.

scientific article

Low level of hepatitis B virus screening among patients receiving chemotherapy

scientific article

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial

scientific article published in June 2006

Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance)

scientific article published on 28 January 2019

Metastatic colorectal cancer: Therapeutic options

scientific article published on September 2006

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.

scientific article published on 06 March 2017

MiR-320e is a novel prognostic biomarker in colorectal cancer.

scientific article

Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials

scientific article published on 23 December 2020

Molecular Classification of Gastric Cancer among Alaska Native People

scientific article published on 13 January 2020

Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes

scientific article

Mutation in BRAF V600E-Reply

scientific article published on 15 June 2017

Mutation‐specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas ⬇️

scientific article published on 08 May 2013

N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer

scientific article

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017

scientific article published on May 2017

New adjuvant therapy for colon cancer: justified hope or commercial hype

scientific article

Occurrence of esophageal and gastric cancer in Alaska Natives, 1969-2003

scientific article published on 01 April 2006

Occurrence of pancreatic, biliary tract, and gallbladder cancers in Alaska Native people, 1973–2007 ⬇️

scientific article published on March 20, 2012

Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials

scientific article

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

scientific article

Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma

scientific article published on 11 June 2014

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group

scientific article published on 22 November 2005

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

scientific article

P-100Phase IB study of sorafenib + evofosfamide in patients (pts) with advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC): NCCTG N1153 (Alliance).

scientific article published on 21 June 2016

PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study

scientific article published on 5 August 2005

Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044

scientific article published in October 2007

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147

scientific article

Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.

scientific article published in January 2007

Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.

scientific article

Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E

scientific article

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity

scientific article published on 01 March 2000

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

scientific article published on 01 April 2000

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks ⬇️

scientific article published on September 1, 1998

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

scientific article

Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer

scientific article published on 18 March 2008

Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors

scientific article

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

scientific article

Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).

scientific article published on 9 December 2016

Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors ⬇️

scientific article published on December 1, 2010

Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma

scientific article published on 11 December 2019

Phase II trial of KW2189 in patients with advanced malignant melanoma

scientific article

Phase II trial of dolastatin-10 in patients with advanced breast cancer

scientific article published on 01 June 2005

Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study

scientific article published on 6 March 2006

Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.

scientific article

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer

scientific article published on 01 March 2006

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group

scientific article

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy

scientific article published on 27 September 2004

Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

scientific article

Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol

scientific article published on 16 July 2015

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

scientific article

Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma

scientific article

Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma

scientific article published on 17 July 2012

Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers

scientific article

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies

scientific article published on 01 September 2019

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

scientific article published on 31 December 2016

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience

scientific article published on 16 February 2018

Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy

scientific article

Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials

scientific article published on 17 December 2020

Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! online

scientific article

Prospective Evaluation of a 12-Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer

scientific article published on 9 August 2016

Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients

scientific article

Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients

scientific article published on 9 July 2015

Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)

scientific article

Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Tri

scientific article published on 01 July 2006

Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)

scientific article published on 23 November 2016

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials

scientific article published on 5 October 2017

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

scientific article

Sex and adverse events of adjuvant chemotherapy in colon cancer: an analysis of 34,640 patients in the ACCENT database

scientific article published on 24 August 2020

Solid Pseudopapillary Neoplasms of the Pancreas: A Large American Cohort

scientific article published on 01 April 2019

Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People

scientific article published on 28 October 2015

Survival and Prognostic Factors in Patients With Solid Pseudopapillary Neoplasms of the Pancreas

scientific article published on 01 September 2018

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†.

scientific article published on 19 February 2015

Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trial

scientific article published in August 2006

The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database

scientific article published on 27 June 2013

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study

scientific article published on 15 December 2020

Therapeutic Advances in GI Malignancies--Fifth Annual Conference. 13-14 July 2007, Newport Beach, CA, USA.

scientific article published in October 2007

Timing means everything, maybe

scientific article published on 23 June 2009

Transplantation for hilar cholangiocarcinoma

scientific article published in October 2004

Treatment advances in liver-limited metastatic colorectal cancer

scientific article published on 05 August 2011

Treatment endpoints for advanced cholangiocarcinoma

scientific article published on 01 November 2004

Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

scientific article published on 12 December 2011

Treatment of liver-limited metastatic colorectal cancer

scientific article published on May 2010

Treatment options for hepatobiliary and pancreatic cancer

scientific article published on May 2007

Update on the optimal management of patients with colorectal liver metastases ⬇️

scientific article published on March 17, 2012

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer

scientific article published on 01 August 2007

Updated options for liver-limited metastatic colorectal cancer

scientific article published on December 2008

Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial

scientific article published on 01 January 2007

Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database

scientific article published on 25 July 2016

Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma

scientific article published on 01 October 2007

Paulina is supported by:

About Paulina

Help